In addition, PAI1, FXIII and tPA gene polymorphisms, known to involve in the clotting pathways, can also impact on the degree of thrombosis and the efficacy of fibrinolysis after stroke [36, 41, 62]. This evidence concerns the gene SERPINE1 and stroke disorder.